vs

Side-by-side financial comparison of CVR ENERGY INC (CVI) and Dexcom (DXCM). Click either name above to swap in a different company.

CVR ENERGY INC is the larger business by last-quarter revenue ($2.0B vs $1.3B, roughly 1.6× Dexcom). Dexcom runs the higher net margin — 21.2% vs -8.1%, a 29.3% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 20.3%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 0.3%).

CVR Energy Inc is a United States-based energy holding company operating two core segments: petroleum refining and nitrogen fertilizer manufacturing. It produces a wide range of products including gasoline, diesel, jet fuel, and agricultural fertilizers, primarily serving commercial, industrial and agricultural customers across North America.

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

CVI vs DXCM — Head-to-Head

Bigger by revenue
CVI
CVI
1.6× larger
CVI
$2.0B
$1.3B
DXCM
Growing faster (revenue YoY)
DXCM
DXCM
+1.3% gap
DXCM
21.6%
20.3%
CVI
Higher net margin
DXCM
DXCM
29.3% more per $
DXCM
21.2%
-8.1%
CVI
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
0.3%
CVI

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CVI
CVI
DXCM
DXCM
Revenue
$2.0B
$1.3B
Net Profit
$-160.0M
$267.3M
Gross Margin
-5.2%
62.9%
Operating Margin
25.6%
Net Margin
-8.1%
21.2%
Revenue YoY
20.3%
21.6%
Net Profit YoY
-56.1%
153.6%
EPS (diluted)
$-1.91
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVI
CVI
DXCM
DXCM
Q1 26
$2.0B
$1.3B
Q4 25
$1.8B
$1.3B
Q3 25
$1.9B
$1.2B
Q2 25
$1.8B
$1.2B
Q1 25
$1.6B
$1.0B
Q4 24
$1.9B
$1.1B
Q3 24
$1.8B
$994.2M
Q2 24
$2.0B
$1.0B
Net Profit
CVI
CVI
DXCM
DXCM
Q1 26
$-160.0M
$267.3M
Q4 25
$-110.0M
$267.3M
Q3 25
$374.0M
$283.8M
Q2 25
$-114.0M
$179.8M
Q1 25
$-123.0M
$105.4M
Q4 24
$28.0M
$151.7M
Q3 24
$-124.0M
$134.6M
Q2 24
$21.0M
$143.5M
Gross Margin
CVI
CVI
DXCM
DXCM
Q1 26
-5.2%
62.9%
Q4 25
-3.1%
62.9%
Q3 25
28.8%
60.5%
Q2 25
-3.7%
59.5%
Q1 25
-5.5%
56.9%
Q4 24
3.0%
58.9%
Q3 24
-3.9%
59.7%
Q2 24
2.9%
62.4%
Operating Margin
CVI
CVI
DXCM
DXCM
Q1 26
25.6%
Q4 25
-5.3%
25.6%
Q3 25
26.3%
20.1%
Q2 25
-5.8%
18.4%
Q1 25
-8.0%
12.9%
Q4 24
1.1%
17.0%
Q3 24
-6.2%
15.3%
Q2 24
1.4%
15.7%
Net Margin
CVI
CVI
DXCM
DXCM
Q1 26
-8.1%
21.2%
Q4 25
-6.1%
21.2%
Q3 25
19.2%
23.5%
Q2 25
-6.5%
15.5%
Q1 25
-7.5%
10.2%
Q4 24
1.4%
13.6%
Q3 24
-6.8%
13.5%
Q2 24
1.1%
14.3%
EPS (diluted)
CVI
CVI
DXCM
DXCM
Q1 26
$-1.91
$0.67
Q4 25
$-1.09
$0.67
Q3 25
$3.72
$0.70
Q2 25
$-1.14
$0.45
Q1 25
$-1.22
$0.27
Q4 24
$0.28
$0.37
Q3 24
$-1.24
$0.34
Q2 24
$0.21
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVI
CVI
DXCM
DXCM
Cash + ST InvestmentsLiquidity on hand
$512.0M
$917.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
Total Assets
$3.9B
$6.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVI
CVI
DXCM
DXCM
Q1 26
$512.0M
$917.7M
Q4 25
$511.0M
$917.7M
Q3 25
$670.0M
$1.8B
Q2 25
$596.0M
$1.2B
Q1 25
$695.0M
$904.9M
Q4 24
$987.0M
$606.1M
Q3 24
$534.0M
$621.2M
Q2 24
$586.0M
$939.2M
Total Debt
CVI
CVI
DXCM
DXCM
Q1 26
Q4 25
$1.8B
Q3 25
$1.8B
Q2 25
$1.8B
Q1 25
$1.9B
Q4 24
$1.9B
Q3 24
$1.6B
Q2 24
$1.6B
Stockholders' Equity
CVI
CVI
DXCM
DXCM
Q1 26
$2.7B
Q4 25
$730.0M
$2.7B
Q3 25
$840.0M
$2.7B
Q2 25
$466.0M
$2.6B
Q1 25
$580.0M
$2.3B
Q4 24
$703.0M
$2.1B
Q3 24
$675.0M
$2.0B
Q2 24
$849.0M
$2.4B
Total Assets
CVI
CVI
DXCM
DXCM
Q1 26
$3.9B
$6.3B
Q4 25
$3.7B
$6.3B
Q3 25
$4.0B
$7.5B
Q2 25
$4.0B
$7.3B
Q1 25
$4.3B
$6.8B
Q4 24
$4.3B
$6.5B
Q3 24
$3.9B
$6.4B
Q2 24
$4.0B
$6.8B
Debt / Equity
CVI
CVI
DXCM
DXCM
Q1 26
Q4 25
2.40×
Q3 25
2.17×
Q2 25
3.97×
Q1 25
3.29×
Q4 24
2.71×
Q3 24
2.33×
Q2 24
1.86×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVI
CVI
DXCM
DXCM
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$21.0M
FCF MarginFCF / Revenue
1.1%
Capex IntensityCapex / Revenue
1.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVI
CVI
DXCM
DXCM
Q1 26
Q4 25
$0
$294.0M
Q3 25
$163.0M
$659.9M
Q2 25
$176.0M
$303.0M
Q1 25
$-195.0M
$183.8M
Q4 24
$98.0M
$301.4M
Q3 24
$48.0M
$199.5M
Q2 24
$81.0M
$279.4M
Free Cash Flow
CVI
CVI
DXCM
DXCM
Q1 26
$21.0M
Q4 25
$192.1M
Q3 25
$125.0M
$579.4M
Q2 25
$135.0M
$208.9M
Q1 25
$-246.0M
$96.8M
Q4 24
$43.0M
$176.8M
Q3 24
$14.0M
$88.3M
Q2 24
$38.0M
$213.3M
FCF Margin
CVI
CVI
DXCM
DXCM
Q1 26
1.1%
Q4 25
15.3%
Q3 25
6.4%
47.9%
Q2 25
7.7%
18.1%
Q1 25
-14.9%
9.3%
Q4 24
2.2%
15.9%
Q3 24
0.8%
8.9%
Q2 24
1.9%
21.2%
Capex Intensity
CVI
CVI
DXCM
DXCM
Q1 26
1.5%
Q4 25
3.0%
8.1%
Q3 25
2.0%
6.7%
Q2 25
2.3%
8.1%
Q1 25
3.1%
8.4%
Q4 24
2.8%
11.2%
Q3 24
1.9%
11.2%
Q2 24
2.2%
6.6%
Cash Conversion
CVI
CVI
DXCM
DXCM
Q1 26
Q4 25
1.10×
Q3 25
0.44×
2.33×
Q2 25
1.69×
Q1 25
1.74×
Q4 24
3.50×
1.99×
Q3 24
1.48×
Q2 24
3.86×
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons